Tim Luetkens

2.1k total citations
57 papers, 1.4k citations indexed

About

Tim Luetkens is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Tim Luetkens has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 34 papers in Oncology and 21 papers in Hematology. Recurrent topics in Tim Luetkens's work include Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (22 papers) and Multiple Myeloma Research and Treatments (18 papers). Tim Luetkens is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), CAR-T cell therapy research (22 papers) and Multiple Myeloma Research and Treatments (18 papers). Tim Luetkens collaborates with scholars based in United States, Germany and Austria. Tim Luetkens's co-authors include Djordje Atanackovic, Nicolaus Kröger, Carsten Bokemeyer, York Hildebrandt, Katrin Bartels, Sabarinath Venniyil Radhakrishnan, Yanran Cao, Sabrina Meyer, Nesrine Lajmi and Sebastian Kobold and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tim Luetkens

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Luetkens United States 23 718 658 469 416 102 57 1.4k
Felix S. Lichtenegger Germany 18 698 1.0× 684 1.0× 428 0.9× 440 1.1× 67 0.7× 35 1.3k
Ai-Hong Zhang United States 17 720 1.0× 455 0.7× 294 0.6× 197 0.5× 157 1.5× 50 1.3k
Todd DeVries United States 16 590 0.8× 666 1.0× 257 0.5× 230 0.6× 151 1.5× 58 1.3k
Karin Schilbach Germany 21 621 0.9× 517 0.8× 274 0.6× 253 0.6× 66 0.6× 45 1.1k
Helga Schmetzer Germany 22 886 1.2× 472 0.7× 330 0.7× 533 1.3× 32 0.3× 93 1.4k
Brandy Perkins United States 13 440 0.6× 369 0.6× 578 1.2× 497 1.2× 31 0.3× 18 1.4k
Jason Foley United States 17 922 1.3× 482 0.7× 280 0.6× 274 0.7× 45 0.4× 24 1.4k
Simon Völkl Germany 23 461 0.6× 392 0.6× 340 0.7× 144 0.3× 53 0.5× 58 1.0k
Benjamin Joachim Schmiedel Germany 21 995 1.4× 488 0.7× 603 1.3× 172 0.4× 69 0.7× 44 1.7k
Francesca Moretta Italy 22 1.2k 1.6× 719 1.1× 182 0.4× 339 0.8× 43 0.4× 36 1.7k

Countries citing papers authored by Tim Luetkens

Since Specialization
Citations

This map shows the geographic impact of Tim Luetkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Luetkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Luetkens more than expected).

Fields of papers citing papers by Tim Luetkens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Luetkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Luetkens. The network helps show where Tim Luetkens may publish in the future.

Co-authorship network of co-authors of Tim Luetkens

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Luetkens. A scholar is included among the top collaborators of Tim Luetkens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Luetkens. Tim Luetkens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kocoglu, Mehmet H., Tim Luetkens, Jacqueline Bork, et al.. (2024). Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells. Blood Advances. 8(22). 5880–5884.
2.
Atanackovic, Djordje, Xiaoxuan Fan, Mehmet H. Kocoglu, et al.. (2024). A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products. Cytotherapy. 26(4). 318–324. 2 indexed citations
3.
Mause, Erica R. Vander, Jillian M. Baker, Sabarinath Venniyil Radhakrishnan, et al.. (2023). Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Science Translational Medicine. 15(705). eadd7900–eadd7900. 17 indexed citations
4.
Chen, Wengen, Michael E. Kallen, Rima Koka, et al.. (2023). Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD). Human Vaccines & Immunotherapeutics. 19(2). 2216116–2216116. 4 indexed citations
5.
Mause, Erica R. Vander, Djordje Atanackovic, Carol S. Lim, & Tim Luetkens. (2022). Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity. Trends in biotechnology. 40(7). 875–890. 25 indexed citations
6.
Atanackovic, Djordje, Forat Lutfi, Diego de Miguel‐Pérez, et al.. (2021). Deep dissection of the antiviral immune profile of patients with COVID-19. Communications Biology. 4(1). 1389–1389. 6 indexed citations
7.
Atanackovic, Djordje, Tim Luetkens, Nancy M. Hardy, et al.. (2021). Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant. Vaccines. 9(7). 737–737. 2 indexed citations
8.
Hankey, Kim G., Tim Luetkens, John C. McLenithan, et al.. (2021). Eight-Day Point of Care CAR T-Cell Manufacturing on Clinimacs Prodigy from Healthy Donors As a Proof-of-Concept Study. Blood. 138(Supplement 1). 2851–2851. 1 indexed citations
9.
Radhakrishnan, Sabarinath Venniyil, Tim Luetkens, Sandra D. Scherer, et al.. (2020). CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Nature Communications. 11(1). 798–798. 57 indexed citations
10.
Bell, Damian C., et al.. (2018). Knotbodies: A New Generation of Ion Channel Therapeutic Biologics Created by Fusing Knottin Toxins into Antibodies. Biophysical Journal. 114(3). 203a–203a. 3 indexed citations
11.
Radhakrishnan, Sabarinath Venniyil, et al.. (2017). Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma. Blood. 130. 3142–3142. 15 indexed citations
12.
Luetkens, Tim, et al.. (2017). In Vivo Vaccination Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab. Blood. 130. 1830–1830. 4 indexed citations
13.
Atanackovic, Djordje, et al.. (2016). Immunotherapies targeting CD38 in Multiple Myeloma. OncoImmunology. 5(11). e1217374–e1217374. 31 indexed citations
14.
Yousef, Sara, Nesrine Lajmi, Katrin Bartels, et al.. (2015). Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma. Journal of Translational Medicine. 13(1). 197–197. 4 indexed citations
15.
Atanackovic, Djordje, Henrike Reinhard, Sabrina Meyer, et al.. (2013). The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting. Human Vaccines & Immunotherapeutics. 9(12). 2533–2542. 22 indexed citations
16.
Pabst, Caroline, Jozef Zustin, Frank Jacobsen, et al.. (2010). Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma. Experimental and Molecular Pathology. 89(2). 175–181. 26 indexed citations
17.
Cao, Yanran, Tim Luetkens, Sebastian Kobold, et al.. (2010). The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients. Experimental Hematology. 38(10). 860–867. 73 indexed citations
18.
Atanackovic, Djordje, York Hildebrandt, Yan Cao, et al.. (2009). Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells. Haematologica. 95(5). 785–793. 79 indexed citations
19.
Atanackovic, Djordje, Tim Luetkens, Jens Panse, et al.. (2008). CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Haematologica. 93(3). 423–430. 53 indexed citations
20.
Panse, Jens, Kay Friedrichs, Alexander Marx, et al.. (2008). Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. British Journal of Cancer. 99(6). 930–938. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix S. Lichtenegger Breakdown of academic impact, for papers by Ai-Hong Zhang Breakdown of academic impact, for papers by Todd DeVries Breakdown of academic impact, for papers by Karin Schilbach Breakdown of academic impact, for papers by Helga Schmetzer Breakdown of academic impact, for papers by Brandy Perkins Breakdown of academic impact, for papers by Jason Foley Breakdown of academic impact, for papers by Simon Völkl Breakdown of academic impact, for papers by Benjamin Joachim Schmiedel Breakdown of academic impact, for papers by Francesca Moretta
Rankless by CCL
2026